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INTRODUCTION
Few environmental contaminants have initiated as much public and legislative outcry as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, dioxin). TCDD is a member of a broader group of halogenated aromatic hydrocarbon (HAH) compounds, which include other polychlorinated dibenzo-p-dioxins, dibenzofurans, biphenyls, diphenyl ethers, and naphthalenes. Many of the HAHs elicit a spectrum of biochemical and toxic effects that are comparable to those observed for TCDD (4, 63, 131) . Members of the family of TCDD-like chemicals are ubiquitous contaminants of the global ecosystem, having been detected in virtually every component of the biosphere, including air, aquatic and marine sediments, fish, and wildlife and human adipose tissue, milk, and blood (9, 19, 35, 138) . Results from studies on the human health effects associated with exposure to TCDD and related compounds are controversial, and molecular and mechanistic studies may provide insights that can be used for hazard and risk assessment of HAHs.
THE ARYL HYDROCARBON RECEPTOR AS A CYTOSOLIC TARGET FOR TCDD
It is generally agreed that the effects of TCDD and related compounds are mediated by interactions with a high-affinity, saturable cytosolic binding protein termed the aryl hydrocarbon receptor (AhR) (128) . Two lines of evidence support this consensus: 1) examination of structure/activity relationships for TCDD and related HAHs demonstrated a correlation between AhR binding affinities and toxichiochemical potencies of these compounds, which also induced the same spectrum of responses; and 2) studies with inbred strains of mice demonstrated differential sensitivity to AhR ligands, which correlated with levels of expression of the high affinity ligand-binding protein (115, 124, 125, (129) (130) (131) 148) . In terms of acute lethality, other hypotheses have been examined, and it has been proposed that the AhR appears to be necessary but not sufficient for transducing the acute lethal toxic zffects of TCDD (16, 123) .
Initial studies by Poland, Nebert, and coworkers (1 15, 125, 129) investigated the induction of hepatic microso-ma1 P-450-dependent aryl hydrocarbon hydroxylase :AHH) activity by 3-methylcholanthrene (MC) in genetcally inbred mice. The induction profiles of AHH activ: ty by MC and TCDD in 2 prototypical mouse strains were highly strain dependent. For example, both TCDD and MC induced AHH activity in the C57BL/6J (Ah responsive) strain, whereas induction by MC was not observed in the Ah-nonresponsive DBA/ZJ strain. Moreover, induction of AHH activity in DBA/2J mice required 10 times higher doses than those used for induction of the same response in C57BL/6J mice. Subsequent structure-induction relationships for a series of HAHs in both strains of mice showed that there was a close correlation between structure-induction and structure-toxicity relationships (130, 149) . Poland and coworkers (128) utilized [3H]TCDD as a radioligand probe and identified a high affinity (K, 5 1 nM), low capacity (<lo0 fmolmg-' protein) AhR protein that bound [3H]TCDD in hepatic cytosol from C57BL/6J mice. It was determined that the requirements for binding to the AhR involve planarity and size, and lateral halogenation is necessary for m aimal binding of HAHs.
The nonresponsive phenotype is inherited as an auto-soma1 recessive trait between the C57BL/6J and DBA/2J strains (170) , and using the Ah-responsive C57BL/6J strain as a background, 2 strains congenic at the AIir locus were developed. The responsive b allele represented the normal gene at the Ahr locus, and the d allele, originally present in the DBN2J strain, designated the nonresponsive genotype. This additional genetic approach to studying HAWAhR relationships avoided the confounding issue of phenotypic differences at other loci (16, 126) . A second responsive allele was later isolated from the C3H and'other responsive mice strains. This second b allele differs structurally from the original b allele (AW-') in that the C57BLI6J b AhR protein has a molecular mass of 95 kDa, whereas a 104-kDa b protein is encoded by the A h P locus in C3H mice (127) . The AhR encoded by A l d is -104 kDa, and no isoforms have been isolated for this allele. Nebert and coworkers (25) characterized nucleotide changes associated with differences in ligand affinities among various alleles of the Ahr locus and reported a total of 10 nucleotide differences between coding domains of the Aid-' and Ah+ alleles, 5 of which are silent. It is hypothesized that a nucleotide change that causes a change from leucine to proline breaks a potential alpha-helix near the glutamine (Q)-rich region and may be responsible for differences in ligand-dependent receptor binding affinities. No significant differences in AhR mRNA levels in tissues of the C57BL/6J and DBA/2J mice have been observed (97).
Development of mouse hepatoma cell lines exhibiting differential responsiveness to TCDD resulted in further genetic characterization of the Ahr locus, and these cell lines have subsequently been used as a valuable tool in molecular mechanistic studies of TCDD action (68) . Of the 3 complementation groups described for mouse liver Hepa-lclc7 cell lines, only the c2 group expressed a mutant AhR, and this group bound ligands with a capacity of <lo% of wildtype cells. The c37 cells expressed a defective CYPlAl protein, and c4 mutants expressed a form of AhR nuclear translocator (Amt) containing a point mutation (G326D) between the Per-AhR-Arnt-Sim (PAS) A and PAS B domains, resulting in a nonfunctional protein with regard to interactions with dimeric partners (75, 117, 142) . Information gleaned from initial studies of the murine AhR supported several conclusions concerning structural and functional aspects of this protein. The AhR has been identified in rodents, humans, fish, marine mammals, birds, and Drosophiln ntelnrrogmter, and physicochemical characteristics of this protein are conserved among species; however, there is little information concerning the phylogenetic location at which AhRs first appeared (33, 61, 67, 150) . Hitherto, no endogenous ligand has been assigned to the AhR, and insight into phylogeny could provide information on the endogenous physiological role of this protein.
In 1995, Fernandez-Salguero and coworkers reported construction of an AhR-deficient (Ah-/-) mouse line by homologous recombination in embryonic stem cells (52) . Although half of the mice died shortly after birth, survivors reached maturity and were fertile. The Ahr-I-mice showed decreased accumulation of lymphocytes in the spleen and lymph nodes but not in the thymus. Moreover, livers of the mice were reduced in size by 50% and showed bile duct fibrosis. Ahr-l-mice were also nonresponsive with regard to TCDD-mediated induction of specific members of the CYP gene family (154) . Whereas Fernandez-Salguero and coworkers produced an exon 1 Ahr deletion (Ahi"lA1), another group generated an exon 2 deletion (Ah$yJ2) (51) . Results obtained from the 2 studies differed significantly (Table I) , and the reason for the differences between the 2 knockout mouse lines is not clear. A recent study (5 1) has amplified initial studies (138) on the AhR knockout mouse, and at doses as high as 2,000 pgkg, mice were resistant to many of the clas-sical AhR-mediated toxicities, particularly in the liver and thymus.
The Ahr-I-lines were developed to investigate the in vivo effects of TCDD in the absence of the AhR and to delineate AhR-dependent and -independent responses. Given the difficulty in developing control mice (i.e., Ahr"') that demonstrate liver pathology comparable to that of the Ahr-l-mice, it is questionable whether the intended experiments will ever be performed. Despite their contradictory nature, results from both knockout studies suggest that the AhR plays an important role in development of the liver and the immune system, offering a potential ontogenetic role for this protein.
Further evidence of a role for the AhR in murine embryonic development was reported by Abbott (1) . 112 situ hybridization and immunohistochemical analysis revealed that AhR mRNA and protein were expressed in multiple tissues at different developmental stages. During gestation days (GD) 10-13, AhR mRNA and protein levels were detected in neuroepithelium and brain, and as development progressed, AhR content of these tissues decreased. The GD 10-12 embryos also expressed AhR in brachial arches, heart, somites, and liver. The GD 14-16 embryos expressed AhR in ectoderm, bone, and muscle. Additionally, both the level and nuclear content of AhR in liver and adrenal tissue peaked during this time. In earlier studies using postpartum animals, other investigators report that receptor levels in rodent lung and liver increased after birth, peaking at 15-21 days and declining through adulthood (60, 88, 157) . Results from these studies imply that the AhR may be important in normal embryonic development, suggesting that TCDD-induced embryotoxicity may be AhR dependent. Molecular cloning of the mouse AhR was completed in 1993; genes encoding the human and rat proteins were cloned in 1993 and 1994, respectively (21, 24, 36, 153). Fitzgerald and coworkers (53) found that expression of mouse AhR vanes widely among cell and tissue types. Analysis of the mouse AhR 5'-regulatory region by several groups demonstrated the presence of tissue-specific cis-regulatory elements such as AP-1, AP-2, Spl, glucocorticoid responsive element (GRE), and CAMP responsive elements (CRE) (2, 108, 153, 183) . These results suggest that expression of the Ahr gene may be regulated in a cell-and/or tissue-specific manner.
THE AHR AND ARNT ARE BASIC HELIX-LOOP-HELIX

TRANSCRIPTION FACTORS
Although structurally distinct from members of other receptor families, the AhR is functionally similar to members of the steroidthyroid hormone receptor superfamily ( Fig. 1 ). Both the AhR and members of the latter group associate with heat shock protein 90 (hsp90), undergo ligand-dependent transformation to a DNA binding form, and activate transcription by interacting with DNA enhancer elements. Members of the steroidthyroid hormone nuclear receptor superfamily contain a zinc finger DNA binding element, and these receptors often bind palindromic cognate DNA binding motifs as homodimers. In contrast, the AhR contains a DNA binding motif rich in basic amino acids and binds a cognate asymmetric DNA responsive element as a heterodimer (41). Furthermore, AhR contains a 200 amino acid functional domain that confers high similarity to the Drosophilu proteins Per (a circadian oscillator protein) and Sim (a central nervous system midline developmental protein) and to Amt, a heterodimeric partner for AhR (75) . The PAS domain may play a role in protein-protein dimerization and is required for dimeric interaction between AhR and Arnt, although the helix-loophelix (HLH) region also mediates intermolecular dimerization (21, 36, 44, 57, 58, 141) . The basic HLH (bHLH) domain is found adjacent to the PAS domain in the AhR, Amt, and Sim proteins but is absent in Per (36, 199) .
The HLH domain is a dimerization interface that mediates homo-and/or heterodimerization with other HLH proteins. The HLH region is generally found contiguous to a sequence of basic amino acids that constitutes the sequence-specific DNA interaction interface. The bHLH proteins are members of the HLH protein family, which includes the bHLH and the leucine zipper-containing bHLHZ proteins. Furthermore, the bHLH family can be subdivided into the class A and class B proteins. Class A bHLH proteins are ubiquitously expressed and dimerize with either class B proteins or other members of class A. In contrast, class B proteins are generally expressed in a tissue-or lineage-dependent manner and form functionally active heterodimers with class A proteins but do not homodimerize (99) . Although not all HLH proteins are transcription factors, most (including AhR and Amt) play some role in transcriptional regulation [reviewed by Littlewood and Evan (99) ]. The bHLH proteins have been implicated in developmental programs such as'neurogenesis, myogenesis, sex determination, lymphopoiesis and hematopoiesis, and angiogenesis in multiple organisms, and recently several new bHLWPAS proteins have been isolated (74, 99, 168, 171, 179, 180, 191, 200) .
The bHLWPAS superfamily of regulatory factors can be divided into 2 general categories: AhR-like (class B bHLH) proteins and Amt-like (class A bHLH) proteins (99, 152) . Transcriptional activation of target genes by b H L W A S factors generally requires homotypic association between a member of the AhR-like class and a member of the Amt-like class with a cognate DNA binding element. The Amt-like proteins invariably recognize a 3'-half-site GTG and appear to be universally required for functional heterodimer formation with the AhR-like proteins (Table 11 ). In contrast, the AhR-like factors are highly selective with regard to core DNA binding sequences and exhibit correspondingly unique basic do-mains, suggesting that the AhR-like component of a bHLH/PAS heterodimer confers specificity for interaction with gene promoters, whereas the Amt-like component may function as a generic coregulator (164) . The discovery of bHLWPAS superfamily proteins is proceeding rapidly, and recent studies have revealed that most of these factors are involved in developmental programs and/or mediate responses to physiologic and environmental stimuli ( Table 11) . A multitude of possible interactions between members of the bHLH/PAS family exist, and each combination potentially constitutes a tissue-, cell-, and promoter-specific mechanism for regulation of gene expression.
The biochemical function of the AhR PAS domain is tripartite. In the cryptic or repressed state, the PAS domain binds with hsp90 (6, 29, 122, 187) . Because the AhR requires activation by an exogenous ligand such as TCDD, in the potentiated state the PAS domain functions as a ligand binding domain and in the activated state it interacts with the PAS domain of the Amt protein to form a functional heterodimer (6, 29, 58, 98, 187) . TCDDregulated gene promoters contain a core enhancer regulatory element known as the xenobiotic or dioxin responsive element (XRE or DRE), which consists of a heptanucleotide core sequence (5'-T(C/T)GCGTG-3') resembling the E box core sequence only in the 3'-half-site (31, 69, 146, 164) . The AhR interacts with the 5'-halfsite T(C/T)GC, whereas the Arnt protein recognizes the 3'-half-site (13) . Furthermore, the AhR-Amt complex displays a preference for nucleotides flanking the core XRE, engendering further TCDD-responsive promoter specificity (30, 164, 197) .
The AhRSArnt complex specifically recognizes and binds the asymmetrical XRE but not the E box sequence 5'-CAGGTG-3', which suggests that the AhR contains a noncanonical DNA recogition sequence for the bHLH transcription factors (166) . The basic region confers a DNA recognition funttion to this class of transcription factors, and it is hypothesized that the unique DNA recognition sequence exhibited by AhR is due to several proline residues within the basic region of this protein (12, 57) . Because proline residues potentially affect protein secondary structure by disrupting a-helices, the findings of Bacsi and Hankinson (12) suggest a non-a-helical DNA binding submotif for AhR. Conversely, the amino acids of Amt that contact DNA are similar to those of other bHLH proteins (166) .
Deletion analysis studies also identified a potent transactivation domain (TAD) within the C-terminal portion of the AhR (82, 94, 102, 145, 187). TADs are generally classified into 3 groups: rich in acidic amino acids (D/E rich), rich in glutamine (Q rich), or rich in a composite of proline/serine/threonine (P/S/T rich) residues (109, 137). The AhR has a complex TAD that harbors glutamine as the preferred residue interspersed with proline/ serinehhreonine and acidic amino acids (187). Using a LexA fusion protein approach, Rowlands et a1 (145) demonstrated that the human AhR TAD is composed of A and B subdomains that activate transcription independently but act synergistically to stimulate transcription in a yeast system. Ma et a1 (102) also observed 2 independent subdomains within the TAD of mouse AhR fusion proteins but with only minimal synergism between the 2 regions. Deletion of the carboxyl terminal half of the mouse AhR but not mouse Arnt eliminates biological activity from the AhR-Arnt complex, suggesting that the Arnt TAD is not necessary for transactivation in the mouse, and Corton and coworkers (28) reported similar results in human cells (58) . In contrast, in reconstitution experiments using mutant AhR and Arnt proteins in which the activation domains of 1 or both components had been deleted, Arnt provided the dominant activation domain in the AhR-Arnt heterodimer complex (187).
However, experiments from all 3 studies were performed using dissimilar promoter constructs. Thus, transactivation strength of the AhR-Amt may be cell-type and promoter specific.
ARNT SERVES AS A COFACTOR FOR MULTIPLE BHLHPAS PARTNERS
The Arnt protein was first identified and characterized as a component of the AhR complex, and it was initially believed that Arnt was required for nuclear translocation of the liganded AhR (20, 41, 75 ,135, 142) . In contrast to the AhR, Arnt does not have ligand binding capabilities and appears to be free from any repressive activity by hsp90 (187). Eguchi and coworkers (40) recently described an N-terminal nuclear localization signal for Arnt that maps to amino acid residues 39-61. The TAD of Arnt is contained within the C-terminal 34 amino acids of this protein and, in contrast to the AhR, the TAD of this protein is P/S/T rich and the Q-rich region does not confer a transactivation function in Arnt (28, 187). P/S/r residues account for the transcriptional activity of other bHLH factors such as c-Myc, where phosphorylation of serine residues is necessary for transcriptional activity. PIS/ T-rich domains may behave in a manner similar to TADs rich in D/E residues (187). TADs of equivalent potency were described for human AhR and Arnt Gal4 fusion constructs (82, 187) . Kobayashi and coworkers recently described an interaction between the TAD of Amt and the CREB binding domain of CBP/p300 and suggested that this molecule may function as a transcriptional coactivator of Arnt (91). In all cases, cell and promoter context may be important factors that determine a transcriptional response 'to functionality conferred by specific TADs.
The constitutive function of Arnt in living systems is unknown, although recent studies have utilized immunohistochemical and molecular biological techniques to explore developmental regulation of Arnt in the mouse embryo (3) . Results from these studies show that the subcellular localization pattern of Arnt is cell type and tissue dependent. Further, like AhR, Arnt expression peaks in neuroepithelial cells of the neural tube, visceral arches, otic and optic placodes, preganglionic complexes, and heart during GD 10-1 1. Maximal expression of Arnt in TOXICOLOGIC PATHOLOGY liver and adrenal gland occurs at GD 15-16. Arnt was also detected in submandibular gland, ectoderm, tongue, bone, and skeletal muscle during this time. A recently described Amt2 protein may function as an Amt-like factor, although it appears that Arnt2 is selectively expressed in brain and kidney in both rat and mouse (38, 74). Furthermore, Hirose and coworkers (74) observed expression of Arnt2 mRNA that was restricted to dorsal neural tube and brachial arch 1 in GD 9.5 mouse embryos. Thus, AhR, Amt, and Arnt2 exhibit dissimilar tissue distribution patterns, suggesting that each protein may play spatially and temporally distinct developmental roles.
Like other class A bHLH factors, Arnt forms homodimers that interact weakly with the core E box DNA sequence (5, 99, 160, 164) . Several investigators have demonstrated the interaction of Arnt with HIFla to form the heterodimeric H F . 1 complex and bind the E box-like hypoxia responsive element (5'-CTAGTG-3') (83, 95, 192) . By generating a targeted disruption of the Arnt locus in the mouse, Maltepe and coworkers (105) dernonstrated that Aritt-'-embryos do not live past GD 10.5 and showed defective vascularization of various developmental structures, leading to embryo wasting. These findings implicate Arnt in a mechanism of cellular adaptation to hypoxia, suggesting a role for this protein that is AhR independent.
AHR-MEDIATED GENE EXPRESSION Interactions with XREs and Other Nuclear Factors
The molecular mechanism of toxic and biochemical responses to TCDD exposure has been characterized primarily through studies of TCDD-induced cytochrome P450IA1 (CYPIAZ) gene transcription (Fig. 2) . AhR-mediated signal transduction occurs through at least 2 compositionally distinct AhR complexes, identified by sedimentation coefficients of 9s and 6s. The 9 s AhR form in Hepa-1 cells is found only in cytosolic fractions and is maintained in an unliganded repressed state by interaction with an hsp90 dimer and perhaps another protein of approximately 43 kDa (26, 121). Arnt is not a constituent of the 9s unliganded receptor complex (135). Using a yeast 2-hybrid screening procedure, Ma and Whitlock (104) cloned a novel protein designated as AhRinteracting protein (AIP). AIP is a cytoplasmic protein and associates with unliganded AhR and hsp90, and overexpression of this factor increases TCDD-induced CYPlAl expression, suggesting that AIP may influence ligand binding andor nuclear targeting of AhR. A recent study by Perdew and Bradfield (122) localized the hsp90 binding region of the murine AhR to amino acid sequences 1-166 and 289-347. Although it does not interact with Amt, the hsp90 dimer appears to be absolutely required for ligand binding by AhR (1 86, 188, 189) . Ligand binding induces dissociation of the hsp90.AhR complex, whereupon the AhR interacts with Arnt. Dimerization of the AhR and Arnt is enhanced by ligands. Singh and colleagues (156) observed a nuclear AhR-Amt complex in HeLa cell extracts in the absence of exogenous ligand (37, 106, 135, 189), which suggests a mechanism of AhR transformation other than exogenous ligand-mediated activation. Lending support to this assumption, there is precedence for ligand-independent activation of receptor systems because both estrogen and progesterone receptors can be activated in the absence of ligand (34, 158). Vol. 26, No. 5, 1998 AH RECEPTOR-MEDIATED SIGNALING 663
The nuclear AhR is generally observed in a complex with Arnt, although Pollenz et a1 (133), using irnmunofluorescence techniques, demonstrated that nuclear translocation of AhR occurred in a mutant Hepa-1 cell line lacking functional Arnt. Moreover, some evidence suggests that hsp90 may play a direct role in translocating the liganded AhR into the nucleus, where Amt promotes dissociation of the hsp9O.AhR complex (58, 78, 107) . The subcellular location of Arnt may also be cell type dependent in that Arnt is a nuclear protein in Hepa-1 cells (78, 133) . Both the 9 s and 6.5 AhR complexes are found in the nuclear fraction of Hepa-1 cells, but only the 6s complex consists of 1 molecule of AhR and 1 molecule of Arnt (41, 135, 142). The molecular mass of the nuclear AhR complex is variable among species, strains, and tissue types, ranging from 180 to 210 kDa (32, 121, 181, 182) . The 6s nuclear heterodimer potentially binds genomic cis-acting XREs located in distal promoter regions of TCDD-regulated genes (54, 55, 64, 84-86, 116, 159) . A common, invariant core sequence for the XRE has been described as 5'-T-GCGTG-3' (30, 146, 197) . The orientation of the AhR-Amt dimer on the XRE was determined by ultraviolet covalent cross-linking, and the results indicated that Arnt contacts the 3'-ward thymidine in the core sequence whereas the AhR binds proximal to this region (1 3). The core XRE sequence has been identified in multiple copies within the enhancer region of the C Y P l A l gene. For example, Lusska et a1 (100) identified 6 distinct sites within the mouse CYPIAI promoter that bind the AhR-Amt complex in Hepa-1 cells. The rat and human C Y P l A l gene promoters contain 2 and 3 copies of the core XRE sequence, respectively (150, 163) .
In addition to positive regulatory sequences, promoter regions of several TCDD-responsive genes also contain negative regulatory elements (NREs). NREs have been identified and characterized in the human and rat CYPIAI gene promoters (73, 162, 178) . Several proteins that constitutively bind this region have been identified and include the nuclear transcription factors OCT-1 and NF-Y (15, 18, 161) . Moreover, superinducibility of CYPIAI mRNA by TCDD has been observed in cells treated with the protein synthesis inhibitor cycloheximide, suggesting that constitutively bound proteins may be involved in negative regulation of CYPIAI gene expression (8, 81, 101, 169) . However,. the function of these regulatory elements is not completely understood and may be species and/or cell-type specific (87) .
Several studies have reported specific protein-DNA interactions within CYPIAI gene promoters that may also influence expression of this gene (22, 66, 70, 119, 143, 184, 194, 196) . Treatment of Hepa-1 cells with TCDD results in binding of the nuclear AhR-Arnt to enhancer sequences and binding of other proteins to G-rich promoter DNA (184, 194) . Camer and coworkers (22) isolated 2 proteins that showed overlapping DNA binding specificities to those of the AhR and identified 1 of the proteins as a member of the C E B P family of transcription factors. Results from these studies suggest that the transcriptional response to TCDD may require multiple protein factors in addition to a functional AhR-Amt complex. In contrast, Henry and coworkers (72) determined that a purified TCDD-AhR complex retains both specific DNA binding and transcriptional activities in a cell-free system.
Activated processive transcription in eukaryotes is a multistep process involving DNA binding by an activator (i.e., AhR.Amt), which interacts with the general transcription factors, coactivators/corepressors, and other nuclear proteins. Initiation of transcription by RNA polymerase 11 requires specific DNA binding at the TATA box by the transcription factor (TF) IID complex, which consists of the TATA-binding protein (TBP) and at least 8 other TATA associating factors (TAFs), and subsequent recruitment of the basal transcription factors TFIIA, TFIIB, TFIIE, TFIIE and TFIIH with the polymerase to form the preinitiation complex. TBP can support basal transcription, but activated transcription requires the presence of TAFs (65) . Transcriptional activators are thought to function by interacting with 1 or more components of the TAF complex to stabilize the preinitiation complex (80, 137, 145, 198) . Although the specific mechanism of AhR-Amt activation of target genes is not clearly understood, 2 major related hypotheses have been advanced. Upon binding to the DRE, AhR-Amt enhances transcription by functioning as an activator through direct interaction and recruitment of basal transcription factors to the promoter and/or by facilitating chromatin derepression and thus enhancing accessibility of promoters to specific and general transcription factors (143, 194) . Binding studies have identified TBP as a possible target for AhR, whereas both the AhR and Amt may interact with general TFIIF (Fig. 3) (145) .
The transcriptional regulatory factor Spl binds GCrich enhancer regions, termed basic transcription elements (BTEs), and interacts with the basal transcriptional machinery. In addition to XRE sequences, the promoters of many TCDD-responsive genes, including CYPIAI, contain BTE sequences. Kobayashi (92) recently demonstrated a synergistic interaction between AhReAmt and Spl. This interaction is mediated by the bHLH and PAS domains of the AhR and Amt proteins and the zinc finger motif of Spl, which contrasts with the hypothesis that the TADs of AhR andor Arnt are largely responsible for interacting with the basal transcriptional apparatus.
ChromatiidHistone Effects
As an alternate but related mechanism, it has been proposed that the AhR-Arnt induces chromatin remodeling TOXICOLOGIC PATHOLOGY and accessibility by initiating or enhancing nucleosomal displacement ( Fig. 4) (39,42, 113, 193) . Nucleosome disruption within the transcribed regions of a gene results from RNA polymerase complexes on the DNA, whereas nucleosome loss within the promoter region is independent of transcription (113). Okino and Whitlock (120) demonstrated that treatment of mouse hepatoma cells with TCDD results in induced binding of the AhR-Amt to enhancer chromatin and that this effect is associated with a localized (-200 bp) alteration in chromatin structure that is manifested by increased accessibility of genomic DNA, suggesting that these changes result from direct disruption of a nucleosome by AhR-Arnt. In contrast, at the Cyplal promoter, TCDD-induced changes in chromatin structure and accessibility occur by a mechanism indirectly rel:ted to AhReAmt binding (120). However, genetic and biochemical studies indicate that a Cterminal region of the AhR contains a latent transactivation function that communicates the induction signal from enhancer to promoter, suggesting that both transactivation and enhancer-promoter communication may be mediated by the AhR. Heterodirnerization activates this latent transactivation function of AhR and silences that of Arnt (89) . Furthermore, the AhR transactivation domain may mediate inducible occupancy of the Cyplal promoter in vivo (90). Histone acetylation is a process that regulates transcription by altering accessibility of chromatin to DNA binding factors. Several components of the basal transcriptional machinery and transcriptional coactivators and corepressors directly modify histones, and it has been hypothesized that histone acetyltransferases may exert positive regulatory influence on such events as promoter recognition and activation by upstream activators (177) . Xu and colleagues (195) utilized the histone deacetylase inhibitor trichostatin A to investigate effects of acetylation on TCDD-induced expression of Cyplal and Cypla2 and EROD activity in primary adult rat hepatocytes. The results suggest that acetylation may play an important role in TCDD-induced gene transcription. Acetyltransferase activity has been observed for the p300/CBP coactivator (1 18 ). This protein interacts with a variety of nuclear hormone receptors and HLH transcription factors, including HIF-la (7, 1 18). Garcia-Villalba and coworkers (59) suggested that histone acetylation may influence thyroid hormone and retinoic acid-mediated gene expressed and thus may play an important role in hormone-mediated transcriptional regulation. Furthermore, the basal transcription factor TFIID, which may interact with the AhR-Arnt complex, also exhibits histone acetyltransferase activity (1 10).
Other Modiilatiiig Factors
In addition to complex spatial requirements within the cell, components of the AhR complex are also regulated by posttranslational modifications. Raunio and Pelkonen (139) first observed the effects of the phorbol ester tetradecanoyl phorbol acetate (TPA) on induction of AHH activity by TCDD-and 3-methylcholanthrene in mice. It was later determined that decreased AHH activity after treatment with TPA was related to downregulation of Cyplal gene transcription and lower DNA binding of the AhR to the XRE (119) . Furthermore, in Hepa-1 cells treated with 10 different protein kinase inhibitors, only the protein kinase C (PKC) inhibitor staurosporine inhibited induction of CYPIAI mRNA levels by TCDD (23). The PKC inhibitor calphostin also gave similar results in human keratinocytes. Moreover, dephosphorylation experiments with individual subunits prior to assembly of the AhR complex on the XRE showed that Arnt requires phosphorylation for heterodimerization and phosphorylation is important for DNA binding of the AhR (14, 27) . Conversely, chemical inhibition of serine/threonine-specific phosphatase activity increased TCDD-dependent transcription of an XRE-containing reporter plasmid (96).
In contrast, PKC is not necessary for iiz vitro transformation of guinea pig, mouse, or rat hepatic cytosol, and depletion of PKC in MCF-7 human breast cancer cells resulted in superinduction of CYPlAl mRNA expression by TCDD accompanied by a 2-to 3-fold increase in nuclear AhR-Arnt levels (112, 151) . Tsai and coworkers (172) observed subcellular distribution of Arnt isoforms with significantly different isoelectric points, which may result from altered levels of phosphorylation. Taken together, these results suggest that posttranslational processing of both the AhR and Arnt proteins constitutes a necessary step in TCDD-induced CYPIAI mRNA expression in some cell lines and target tissues. Enan and Matsumura (17, 50) reported that treatment of either NIH 3T3 cells or guinea pigs with TCDD results in increased pp6OC-"" (Src) activity and that Src is specifically associated with the AhR. Src is the main protein kinase specifically associated with the AhR and is activated upon ligand binding, presumably by a conformational change induced by dissociation of the AhR (50) . Src functions as a component of the tyrosine phosphorylation cascade for the estrogen receptor and several growth factors (174) . The major phosphorylation targets of Src include c-ras, p42-p44mapk2, and AP-1 proteins, all of which are activated by TCDD in adipose tissue of male guinea pigs (46) (47) (48) (49) 173) . Ma and Whitlock (103) and Weib and coworkers (185) independently reported an AhR-dependent, TCDD-independent delay in GI-S cell cycle phase progression in Hepa-lclc7 and 5L hepatoma cells, respectively. Because Src is required for cell division in some cells, a functional AhR may be necessary for cell cycle progression and this may be a cell-type specific process (144).
Other factors also modulate TCDD-induced expression of CYPIAI, and these include the cytokines interleukin (IL)-lp and IL-6 and the growth factors epidermal growth factor, transforming growth factor (TGF)-a and TGF-p (10, 56, 77, 176) . Oxidative stress may also contribute to inhibition of CYPlAl expression (1 1). These interactions are probably cell-type specific (150) . Sadek and Allen-Hoffman (147) reported suspension-mediated induction of Cyplal in Hepa-1 cells and that this process is dependent on a functional AhR complex. Thus, there may be a novel mechanism for induction of Cyplal that may be related to cytoskeletal features exhibited by the Hepa-1 cells. Methylation protection and methylation interference assays indicate that DNA methylation can diminish the response to TCDD by impeding the AhR-XRE interaction (155) . In addition, Reiners and coworkers (140) reported that the p21-ras protein controls signal transduction pathways that can downregulate AhR function through an unknown mechanism.
The fate of the AhR and Arnt proteins following ligand and DNA binding could also affect the transcriptional response of CYPlAl to TCDD. The relative resistance of TCDD, to metabolism confers the potential to maintain activation of the AhR for sustained periods. Thus, changes in AhR or Arnt protein levels could affect the ability of TCDD to induce or maintain a transcriptional response. Results from several studies utilizing specific [3H]TCDD binding or western blot analysis suggest that the AhR but not the Arnt protein is depleted in nuclear and cytosolic extracts and whole cell lysate after exposure of Hepa-1 cells to TCDD for 6 hr (62, 71, 132, 136, 165) . Moreover, basal concentrations of AhR or Arnt protein did not affect the rate or degree of AhR depletion (132). The changes observed in levels of AhR but not Arnt suggest that AhR-Arnt heterodimerization is a dynamic process and that, although AhR may be degraded preferentially, Arnt performs a variety of cellular functions that require high basal levels of this protein.
In addition to regulating expression of CYPIAI, the AhR-Arnt complex initiates transcription of several phase I drug-metabolizing enzymes (DME), including CYPlB 1 and CYPlA2 (190) . Moreover, several phase I1 DME TOXICOLOGIC PATHOLOGY gene products are TCDD inducible in Ah-responsive sys-REFERENCES tems, including UDP-glucuronosyltransferase, glutathione-S-transferase (GST), 6-aminolevulinic acid synthase, epidermal transglutaminase, aldehyde-3-dehydrogenase, and NADPH : quinone oxidoreductase/menadione oxidoreductase (150) . The 4 members of the murine phase I1 Ah gene battery may also be involved in the cellular response to oxidative stress, and the AhR may interact with the electrophile response element-binding transcriptional complex associated with the oxidative stress response (1 75) .
Most previous studies have focused on characterizing diverse factors that regulate Ah responsiveness using the CYPlAl gene or a region of the CYPlAl gene promoter as models. For example, research in this laboratory has demonstrated that TCDD did not induce reporter gene activity (i.e., chloramphenicol acetyltransferase [CAT]) in estrogen receptor (ER)-negative MDA-MB-23 1 cells transiently transfected with an Ah-responsive construct (pRNH1 1C) containing a human CYPIAI gene promoter (-1 140 to +2434). However, TCDD induced CAT activity in cells cotransfected with pRNH11C and a human ER expression plasmid. Similar results were obtained using a minimal DRE CAT construct. In contrast, TCDD did not induce GSTn mRNA levels, GST-dependent activity, or reporter gene activity in cells transiently transfected with constructs contain GSTn (human) (-291 to +36) or GSTP (rat) (-2900 to +59) promoter inserts. In contrast, GST is inducible by TCDD in other cell types. These results illustrate that factors that affect Ah responsiveness may also be gene/promoter specific and depend not only on DRE enhancer elements but also on 5' flanking regions that bind other nuclear transcription factors that regulate basal and inducible gene expression.
SUhlhl ARY
The AhR plays a unique role among bHLWPAS proteins, and it is the only known protein in this superfamily to require activation by an exogenous ligand. The constitutive function of this receptor and the identity of its endogenous ligand remains elusive. In contrast, recent studies suggest that Arnt does not associate exclusively with AhR, but it promiscuously serves as a cofactor for bHLWPAS proteins of diverse function. It is rapidly becoming apparent that Arnt, and not AhR, plays a vital role in a multitude of cell types and tissues. Studies using knockout mouse technology have demonstrated that elimination of Arnt through expression of a null allele results in embryonic death (103, whereas elimination of AhR expression results in pathology of several organ systems but not in death (52, 154) . Future research can utilize results of molecular studies to determine the role of bHLH/PAS protein-mediated gene expression and the certain role of cross-talk between these systems in normal developmental processes and in ligand-induced biochemical and toxic responses in target cells and tissues.
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